Firebrick must walk fine line between ‘nasal hygiene’ and therapeutic claims

The Aussie pharma will launch its Nasodine nasal spray on the US market but without FDA approval therapeutic claims are a no-no.

The Aussie pharma will launch its Nasodine nasal spray on the US market but without FDA approval therapeutic claims are a no-no.